Rituximab With Involved Field Irradiation for Early-stage Nodal Follicular Lymphoma: Results of the MIR Study

The MabThera and Involved field Radiotherapy study investigated efficacy and safety of involved field (IF) radiotherapy in combination with the anti-CD20 antibody Rituximab for early-stage follicular lymphoma (FL) in a prospective, single-arm multicenter phase 2 design. Eighty-five stage I–II FL pat...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hemasphere
Main Authors: Herfarth, Klaus, Borchmann, Peter, Schnaidt, Sven, Hohloch, Karin, Budach, Volker, Engelhard, Marianne, Viardot, Andreas, Engenhart-Cabillic, Rita, Keller, Ulrich, Reinartz, Gabriele, Eich, Hans-Theodor, Witzens-Harig, Mathias, Hess, Clemens F., Dörken, Bernd, Dürig, Jan, Wiegel, Thomas, Hiddemann, Wolfgang, Hoster, Eva, Pott, Christiane, Dreyling, Martin
Formato: Artigo
Idioma:Inglês
Publicado em: Wolters Kluwer Health 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6745956/
https://ncbi.nlm.nih.gov/pubmed/31723798
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/HS9.0000000000000160
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados